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Spontaneously arisingNK cells andNK cells activated in vivo in response to IFNs
are predominantly a population ofCD3- , TCR - cells (1-4) having the morphology
of large granular lymphocytes (LGLs) l (5, 6) . They mediate lysis of a restricted
range of target cells without apparent antigen specificity or restriction by histocom-
patibility molecules (7, 8). IL-2, originally isolated as a growth factor forT cells,
hasbeen shownto activateNK cells to lyse sensitive target cellsmore efficiently both
in vivo and in vitro, and to support the proliferation ofNK cells in vitro (2, 9-14).
As of yet, however, IL-2 support ofNK cell proliferation in vivo has not been estab-
lished (15) . Although previous reports have suggested that administration of IL-2
can supportNK cell proliferation in vivo, these studieswere carried outby prolonged
and repeated exposure of mice to IL-2 (13, 14) . Such protocols may have activated
other cells, including T cells, to produce intermediary factors supporting NK cell
proliferation . Furthermore, these studies were limited, as characterizations of the
NK cells andNK cell expansion were based on functional analyses ofcell-mediated
lysis and appearance of cells having LGL morphology. Both of these characteristics
are not specific to NK cells and can be shared by other cell types, including IL-2-
activatedT cells (16, 17) . Thus, a physiological role for IL-2 inNK cell proliferation
in vivo has not been documented .
Ourlaboratory has been studying the regulation ofNK cell andT cell prolifera-
tion in vivo (15, 18-20) . We have previously shown that both populations of cells
undergo proliferation during viral infections. The kinetics of these two responses
differ in thatNK cells proliferate at earlytimes post-infection with lymphocytic cho-
riomeningitis virus (LCMV), whereasT cells proliferate at later times (15, 17, 18).
The NK cell proliferation correlates with production of virus-induced IFNs, and
administration ofIFNs alone caninduce theproliferation ofNK cells (19) . The cells
responding to IFN signals are CD3 - (4) and are readily elicited in athymic mice
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(4, 15). In contrast to NK cell proliferation, T cell proliferation correlates with the
production ofIL-2 (18). It was striking to note, in these studies ofLCMV infection,
that peak IL-2 production was apparent only after NK cell proliferation had sub-
sided (18).
The experiments reported here were undertaken to directly examine the respon-
siveness of murine NK cells to IL-2 in vivo. To carry out these studies, we asked
ifrIL-2 could induce NK cell proliferation, within a 24-hperiod, in athymic as well
as euthymic mice. In addition, induction ofthe gene for the p55 cx chain molecule
ofthe IL-2-R was examined in populations of cells responding to various in vivo
activation/proliferation signals, includingIL-2, IFN, and infection with LCMV We
report here that: (a) high doses ofIL-2 in vivo can induce the proliferation of NK
cells within a24-hperiod; (b) administration ofIL-2 in vivo results in the accumula-
tion of transcripts for the p55 a chain gene in euthymic mice but not in athymic
mice; (c) thekineticsofp55a chain transcription during LCMVinfectioncorrelates
with T cell proliferation as opposed to NK cell proliferation; and (d) murine NK
cells are not induced to transcribe detectable levels of the p55 a chain gene, even
when they are induced toproliferate in response to IL-2 in vivo. Theresultsdemon-
strate that IL-2 can be a growth factor for NK cells in vivo, but suggest that the
role of this factor in supporting murine NK cell proliferation in vivo is limited.
Materials and Methods
Mice.
￿
C3H/HeJ (H-2') and C57BL/6 (H-2e) mice were purchased from TheJackson
Laboratory, Bar Harbor, ME. Specific pathogen-freeathymicnudemiceand euthymic nude/+
littermates (BALB/cAnBOM)were bred in ourisolated facility. All food, bedding, and cage
materials were presterilized. Experiments were done with 4-20-wk-old mice.
Treatment ofMice.
￿
Mice infected with the Armstrong strain of LCMV were injected in-
traperitoneally with 2 x 104 plaque-forming units ofvirus (15, 17). Mice were killed at 0-9 d
post-infection. When stated, mice were treated intraperitoneally with 100 hg ofthe chemical
IFN inducer polyinosinic-polycytidylic acid (poly I:C; Sigma Chemical Co., St. Louis, MO).
Mice receiving human rIL-2 or highly purified mouse IFN-S were injected intravenously
18-24 h before harvest. The rIL-2 (des-ala-ser125), a generous gift ofCetus Corp., Emeryville,
CA, had a sp act of 8 x 106 BRMP U/mg protein. All reported IL-2 U are BRMP U. 8 x
106 BRMP U is equal to 1.8 x 107 IU. The IFN-Q, purchased from Lee Biomolecular, San
Diego, CA, had a sp act of 2 x 10' international reference units/mg protein. Concentrations
administered to mice were as stated.
Antibodies.
￿
The mAbs B23 .1, directed against monocyte/macrophages (21), and Jlld,
directed against polymorphonuclear leukoctyes and most B cells (22), were used with rabbit
H-2 complement (RbC; Pel-Freez Biologicals, Rogers, AR) during the purification ofin vivo
activated lymphocytes as previously described (4, 20). The mouse anti-NK1.I mAb, PK136
(23), was used to stain the NK cell subset in C57BL/6 mice. The PK136 antibody is of the
IgG2b isotype. Staining was carried out with fluorescein-conjugated goat antibody, Fab'2,
specific for mouse IgG Fc fragment (Jackson Immunoresearch Labs., West Grove, PA). The
following mAbs, as well as PK136, were used with RbC' to phenotype the activated killer
cells: 3.155, anti-Lyt-2 .2 (24); GK1.5.6, anti-L3T4 (25); SH34, antiasialo ganglio-n-tetra-
osylceramide (anti-AGMI) (26); and 29B, anti-CD3 (27). The MARS 18.5 (28) was used
to enhance complement fixation when required.
Isolation ofIn Vivo Elicited Cell Fbpulations.
￿
Spleen cells were isolated from mice after the
various treatment protocols as stated. RBC were lysed by treatment with ammonium chlo-
ride. Leukocytes were separated on the basis ofsize with an elutriation system (JE-6B; Beckman
Instruments, Inc., Palo Alto, CA) as previously described (4, 15). Briefly, cells were loaded
into the centrifugal rotor, which was spinning at 3,200 rpm. The flow rates for elutriationBIRON ET AL.
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fractions 1-6 were 15, 22, 28, 32, 38, and 46 ml/min, respectively. Using these conditions
for separations, we have previously demonstrated that fractions 4-6 are enriched by three
to ninefold for lymphocytes incorporating the DNA precursor [3H]thymidine (15). Total non-
B lymphocytes were isolated afterdepletion of macrophages, polymorphonuclear leukocytes,
and B cellsby antibody (B23.1 and J11d) and RbC' treatments. Total viable non-B lympho-
cytes were recovered after treatments by centrifugation over a one-step, 38% Percoll (Phar-
macia Fine Chemicals, Uppsala, Sweden) density gradient.
Chromium Release Cytotoxicity Assays.
￿
Target cells labeled with S'Cr (New England Nuclear,
Boston, MA) were incubated with spleen cells for 5 h at 37oC in microtiter plates as described
(15). Spontaneous lysis was determined by incubating medium with targets for 5 h. Max-
imum "Cr release was determined by adding 1% NP-40 to target cells. Percentage of lysis
was calculated as: 100 x (cpm test sample lysis - cpm spontaneous lysis)/(cpm maximum
release - cpm spontaneous lysis). NK cell activity was analyzed as cytotoxicity against the
NK-sensitive target cell line, YAC-1. The NK-resistant cell line, P815, was examined to deter-
mine target cell range. CTL activity was determined as virus-specific lysis ofhistocompatible
target cells, as described previously (17, 18).
Northern Blot Analysis.
￿
Cytoplasmic RNA was isolated from cells lysed by NP-40 in the
presence of RNase inhibitors (4). Nuclei were removed by centrifugation and RNA was pre-
paredfrom supernatant by proteinase K digestion, phenol extraction, and ethanol precipita-
tion. Samples (10-20 Rg) were denatured by heating at 55°C in 50% formamide and sepa-
rated by electrophoresis in a 1.2% agarose formaldehyde gel. The RNA was transferred to
Biodyne filters (ICN Biomedicals, Inc., Irvine, CA), and the filters were baked for 2 h at
800C. A first prehybridization wash was carried out for 30 min in 5 x SSC (5 x 0.75 M so-
dium chloride and 0.075 M trisodium citrate), 5 x Denhardts, 50 mM sodium phosphate,
pH 6.5, 0.1% SDS, and 250 kg/ml salmon sperm DNA. DNA probes were "P labeled using
the random hexanucleotide priming kit from Boehringer Mannheim Biochemicals (Indi-
anapolis, IN). Hybridizations were carried out overnight. Filters were washed three times
in 2 x SSC with 0.1% SDS at room temperature, followed by two washes under stringent
conditions in 0.1 x SSC and 0.1% SDS at 55°C. Probes were derived from plasmids carrying
cDNA or DNA inserts coding for the p55 a chain of the mouse IL-2-R (29), obtained from
Dr. Ron Germain of the NIH, Betheseda, MD; mouse IFN--y, obtained from Dr. Ken-ichi
Arai, DNAX Research Institute, Palo Alto, CA; and S-actin (30).
InSitu Hybridization.
￿
The DNA insert complementary to the murine IL-2-R a chain gene
was isolated, labeled with 3sS dCTP by random hexanucleotide priming to a sp act of >10'
cpm/Ag, and denatured in 100% formamide at 90°C. The cellsto be probed were spun onto
microscope slides using a cytocentrifuge (Shandon Inc., Pittsburgh, PA), fixed in 4% para-
formaldehyde for 15 min at room temperature, then dehydrated and stored in 70% ethanol
at 4'C until use. They were rehydrated before use in Mgt*-PBS, then treated with 50%
formamide at 70°C for 15 min. Hybridizations were performed as previously described with
minor modification (18). The hybridizations were carried out for 3 h at 37oC. The slides
were then washed extensively in formamide and SSC, dried, dipped in nuclear track emul-
sion (type NTB-2; Kodak, Rochester, NY), exposed at 4°C for 7-10 d, and developed. Plasmid
controls were done similarly.
Cell Cycle Analysis.
￿
Cell cycle analyses were done by quantitative staining of DNA with
propidium iodide (PI) (4). Briefly, cells were fixed in 70% ethanol, washed in PBS, and
resuspended in 20 g.g/pl PI (SigmaChemical Co.) with 50 j.g/ml ribonuclease A (SigmaChem-
ical Co.).
Flow Cytometric Analysis.
￿
A FACS 440 (Becton Dickinson & Co., Mountain View, CA)
was used fur analyses. Laseroutput was 300 mW at 488 nm. Green fluorescence was collected
through a DF585/40-nm filter. For cell cycleanalysis with PI stain, emitted lightwas collected
through a 625/35-nm filter. The green fluorescence signals were amplified logarithmically.
The PI signals were amplifiedwith a linear amplifier. In certain experiments, cellswere sorted
on the basis of green fluorescence.
CytochemicalStaining.
￿
Cells were sedimentedin a cytocentrifuge(Shandon Inc.), air dried,
and stained with Wright's Giemsa. All buffers were at pH 7.2. Morphology was examined
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Results
Activation ofNK Cells In Vivo After Administration ofrIL-2.
￿
To determine the con-
centrations of rIL-2 required for induction and/or enhancement of NK cell activity
during an 18-24-h period in vivo, mice were treated with rIL-2 intravenously, and
cytotoxic activity mediated by total spleen cell populations was measured against
NK-sensitive YAC-1 target cells (Table I). The nu/+ BALB/c mice maintained in
our sterile colony hadnondetectableendogenous NK cell activity. This result is con-
sistent with earlier reports from other laboratories using germ-free animals. Treat-
ment with low-dose rIL-2 (3 x 104 U) resulted in marginally detectable activity
(Table I; 2% lysis at E/T ratios of 100). In contrast, treatment with high-dose rIL-2
(106 U) induced a >10-fold increase in killing of YAC-1 cells (Table I; 20% lysis at
E/Tratios of 100). Cytotoxicactivity wasreadilydetectable in conventionally housed
normal C3H and C57BL/6 mice, and this activity could also be induced in response
to treatment with higher dosages of IL-2 (Table I). Experiments with spleen cells
isolated from untreated athymicnu/nu BALB/c mice maintained in our sterile colony
demonstrated that these cells had low but detectable cytotoxic activity, mediating
6-8% lysis of YAC-1 cells at E/T ratios of 100. Treatment of the nude mice with
low-dose rIL-2 resulted in a threefold increase in YAC-1 target cell lysis. High-dose
rIL-2 treatment induced a greater than fivefold increase in activity (Table I).
The killer cells induced by treatment with rIL-2 were characterized as NK cells
TABLE I
Activation of NK Cells In Vivo After Administration of IL-2
Percent lysis of YAC-1
Mice were treated at 20-24 h before harvest, as described in Materials and
Methods. Spleen cells were examined.
Cytotoxicity was determined in a 4-8-h 5 'Cr release assay.
I Total spleen cell populations were examined to determine percent LGL.
S Controls in these experiments received excipient control that did not contain
IL-2 . In all other aspects, it was equivalent to the preparation of rIL-2.
II Lysis was measured at an E/T of 50.
Lysis was measured at an E/T of 25.
" Lysis was measured at an E/T of 12.
Mice Treatment 100
target cells'
33
EIT
11
Percent
LGLI
Nul+ BALB/c control§ 1 <1 <1 1
3 x 104 U rIL-2 2 1 <1 2
NulNu BALB/c control§ 8 4 3 2
3 x 104 U rIL-2 26 13 6 3
Nul+ BALB/c control <1 <1 <1 2
106 U rIL-2 20 11 6 7
NulNu BALB/c control 6 4 2 2
106 U rIL-2 34 22 11 7
C3H Control 18 11 7 3
3 x 105 U rIL-2 24 37 23 8
C57BL/6 Control 411 31 2"" 1
106 U rIL-2 1811 91 9"" 5BIRON ET AL.
by the following criteria. (a) They were readily elicited in the athymic nude mice.
(b) The cell surface phenotype ofthe cytotoxic cells induced by IL-2 was that of
NK cells (Table II); the killer cells elicited in C57BL/6 mice expressed the NK
cell-specific alloantigen, NK1.l, andhighasialo ganglio-n-tetraosylceramide (AGMI),
characteristic of NK cells. They did not express the T cell markers Lyt-2, L3T4,
or CD3. (c) The activated cells demonstrated the target cell range ofNK cells; lysis
ofthe NK-sensitive target, YAC-1, was elevated to high percentages, whereas lysis
ofthe NK cell resistant target, P815, was constantly <1% with all mice examined
(data not shown). (d) IL-2 treatment resulted in an increase in the percentages of
cells having the LGL morphology characteristic of NK cells (Table I).
BlastogenesisandProliferation ofNKCellsAfter Treatmentwith rIL-2.
￿
The observation
that LGL percentages were increased after treatment with IL-2 suggested that the
NK cells were expanding in response to IL-2 in vivo. As the LGL morphology can
be induced after activation of NK precursor cells (31), and as the morphology is
not absolutely unique to the NK cell subset (16, 17), the increase in LGL percen-
tages is consistent with, but does not prove that, NK cells are dividing in response
to IL-2 in vivo. We have previously shown that NK cells undergoing blastogenesis
and proliferation can be isolated in fractions ofblast size cells (15). To determine
whetherornot IL-2 induced blast size NKcells invivo, spleen leukocytes were sepa-
rated by elutriator centrifugation into six fractions. Fraction 1 contained the smallest
size cells, residual erythrocytes, and the dead cells and cell debris. Fraction 6 con-
TABLE II
Characterization of IL-2-activated YAC-1 Killer Cells
Experiments were carried out with C57BL/6 mice. Mice were control treat-
ed, treated with >5 x 105 U of IFN, or treated with >5 x 105 U of rIL-2.
Antibody and RbC' treatments of killer cells were as described in Materials
and Methods. Cytotoxicity was measured in a 4-5-h 5'Cr release assay against
YAC-1 target cells at ratios of50:1, 25:1, 12:1, and 6:1 . Under the conditions
used, anti-NK1 .1 and anti-AGM1 resulted in <10% inhibition, anti-Lyt-2
resulted in >90% inhibition, and anti-CD3 resulted in a 27-48% inhibition
of virus-specific cytotoxic T cell-mediated lysis on day 7 post-infection with
LCMV.
Experiment 1 was carried out with populations that had been enriched for NK
cell activity by depletion of Jl ld` and B23.1' cells.
t Experiment 2 was carried out with total spleen cell populations. An addition-
al E/T ratio of 100:1 was used.
S It was not possible to determine percent reduction of control cells in this ex-
periment, as the control NK cells mediated <1 % of YAC-1 target cells at all
of the ratios examined.
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Percent reduction of YAC-1
Exp.
Antibody
treatment
with RbC' Control
target cell lysis
IFN-
cells activated cells
IL-2-
activated cells
1' Anti-NK1 .1 41 59 45
Anti-Lyt-2 <1 4 <1
Anti-L3T4 <1 2 <1
21 Anti-NK1 .1 -S 100 100
Anti-AGM1 - 100 100
Anti-CD3 - <1 <117$ RESPONSIVENESS OF NATURAL KILLER CELLS TO INTERLEUKIN 2
tained the largest size cells. Under the conditions used, fractions 2 and 3 were en-
riched for small to medium size lymphocytes in Go/Gi of the cell cycle, whereas frac-
tions 4, 5, and 6 were enriched for large size cells and blast lymphocytes in S and
G2/M phases of the cell cycle (4, 15). The cytolyticactivity ofthevarious size spleen
cell populations isolated from control and IL-2-treated mice was determined against
YAC-1 target cells.
In both athymic and euthymic mice, only populations of cells that mediated NK
cell activity when isolated from untreated mice were enhanced after treatmentwith
low-dose IL-2. Cells mediatinglysis isolated from aythmic nude mice were enriched
in the medium size populations recovered in fraction 3, however, modest cytolytic
activity was detected with cells recovered in each of the size classes. Treatment of
the athymic mice with low-dose (3 x 104 U) rIL-2 resulted in an enhancement of
activity mediated by cells from each ofthe size classes, and the cytotoxic cells were
still enriched in fraction 3 (Fig. 1 A). Euthymic mice had marginally detectable ac-
tivity mediated only by cells recoveredin fraction 3, and treatment of euthymic nu/+
mice with low-dose rIL-2 (Fig. 1 B) enhanced only the activity mediated by this
population. The level of enhancement was approximately proportional in each of
the lyticsubsets. These results areconsistent with enhancementof activity mediated
by pre-existing NK cells. In contrast, high-dose rIL-2 (106 U) induced proportion-
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FIGURE 1.
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ally more activity mediated by blast size cells than by small to medium size cells.
This was observed in both athymic nude BALB/c (Fig. 1 C) and euthymic nu/+
BALB/c (Fig. 1 D). High-dose rIL-2 also induced proportionally more activity in
blast size cellsisolatedfromC3H and C57BL/6mice (datanot shown). Theseresults
demonstrate that high-dose IL-2 induces blast size NK cells. We have previously
demonstrated that IFNs and IFN induers elicit NK cell blastogenesis in vivo. The
induction ofNK cell blastogenesis by 105 UofIFN-S, during the same time period
in nude mice, is presented in Fig. 1 C for comparison.
To determine ifthe NK cells were undergoing DNA synthesis and proliferation
in addition tobecoming blastsize cells, experimentswere undertaken usingtheNKLI
alloantigen-positive C57BL/6 mice. As stated previously, the NK1.1 determinant is
specifically expressed on CD3- NK cells isolated from these mice (3). The numbers
of NK1.1' cells within populations oflymphocytes from C57BL/6 mice was deter-
mined using flow cytometry. Total numbers of NK1.1' cells were increased twofold
after high-dose treatment with IL-2 for 24 h.
Cell cycle analyses were carried out by labeling with the quantitative DNA stain,
PI. DNA content within the NK cell subset was measured by two-colorfluorescence
analysis using fluorescein-conjugated NK1.1 (green) and PI (red). The increase in
NK1.1' cells was accompanied by a preferential increase in the cycling ofthe NK1.1'
cell subsets after treatment with IL-2. These experiments were first carried out by
examining the NK1.1* cells within the total spleen cell population (data not shown).
As the NK1.1' cell populations within the subsets were very small, <5-10%, the ex-
periments were also carried out with populations enriched in NK1.1' cells, >10-
20%, after depletion ofBcells, macrophages, andpolymorphonuclearcells(PMNs).
For these experiments, cells were prepared from control mice, mice that had been
treated with 5 x 105 LJ of rIL-2, and mice that had been treated with 5 x 105 U
of IFN-/3. The treatmentofmice with either high-dose AL-2 or IFN-a resulted in
a modest increase intheproportion ofnon-Blymphocytesin the S and G2/M phases
of the cell cycle (Fig. 2). When the NK1.1 + cell subset was specifically examined,
it was clear that the increase in cycling cells preferentially occurred in the NK cell
subset; after treatment with either rIL-2 or IFN-/3, almost 50% ofthe NK1.1' cells
were in S and G2/M phases ofthe cell cycle (Fig. 2). These results demonstrated
the IL-2-induced blastogenesis and proliferation of NK cell subsets in vivo.
Induction ofthe IL-2-R p55 a Chain in Response to IL-2 In Vivo.
￿
Reponsiveness to
IL-2 is regulated by the expression ofthe IL-2-R. Work from otherlaboratories has
demonstrated that IL-2 inducesthe transcription ofthe gene forthe ap55 molecule
ofthe IL-2-R (32-34). To evaluate the induction of the IL-2-R p55 chain during
NK cell proliferation, RNA was prepared from blast lymphocytes after treatments
to induce blastogenesis in vivo. The blast cell populations were isolated to select for
the minority ofthe total spleen cells that had responded to the in vivo treatments.
Blast cells ofinterest were further enriched by antibody and C' depletion ofB cells,
macrophages, and PMNs. Viable cells were recovered bydensity gradient centrifu-
gation. We have previously demonstrated that this isolation procedure selects for
the dividing non-B lymphocytes and that thesecellsrepresent<10% ofthe total spleen
cell populations (4).
For these experiments, RNA was prepared from a panel ofdividing non-B lym-
phocytes that had been elicited in vivo, as well as from in vitro maintained cells180 RESPONSIVENESS OF NATURAL KILLER CELLS TO INTERLEUKIN 2
TOTAL NON-S LYMPHOCYTES
￿
NE1.1+ LYMPHOCYTES
UNTREATED
ILS-TREATED
IFN-TREATED
FLUORESCENCE INTENSITY
PI STAIN
FIGURE 2.
￿
Cell cycleanalyses aftertreatments with IL-2 or IFN. Non-B lymphocytes were iso-
lated from C57BL/6control mice, mice that had been treated with 5 x 10 5 U rIL-2, and mice
that had been treated with 5 x 105Uof IFN-0at 24 hbefore experiment. Thecells were stained,
as described in the Materials and Methods, with fluorescein-conjugated reagents to mark the
NK1.l' cell subset, and PI to quantitatively stain DNA content. Cell cycle analyses presented
in the panels on theleft were performed usingthe totalnon-Blymphocyte population. Cell cycle
analyses presented on the right were performed by acquiring data gated for only the green,
NK1.I' cells. Lowintensity cellsin theGO-GI phase of thecell cycle, thus having 1x DNA con-
tent, are found in the first peaks. High intensity peaks are cells with 2x DNA content are in
the G2-M phases of the cell cycle. The broad distribution of cells in the center are in S phase
with >1 x but <2 x DNA. Gaussian curve fit analyses were carriedout to determine proportions
of cells in each phase of the cell cycle. Shown in parentheses are the percentages of cells with
>1 x content of DNA, i.e., in S and G2-M phases.
known to be positive for p55 gene transcription. Northern blot analysis was carried
out withthese samples (Fig. 3). Transcription ofthep55 gene was readily detectable
when IL-2 was present ineuthymic mice in vivo. Themultiple transcripts character-
istic for the p55 gene (29) were observed with RNA isolated from C3H mice that
had received high-dose rIL-2 (Fig. 3, lane 6). We have previously shown that IL-2BIRON ET AL .
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FIGURE 3 .
￿
Northern blot analysis for expression of the IL-2-11 p55 achain gene. Blastnon-B
lymphocytes were prepared after various protocols to activate lymphocytes in vivo, as described
in Materials and Methods . Cellular RNA was isolated and used in the following lanes: (1)an
IL-2-dependent line ; (2) blast NK cells isolated from C3H mice that had been treated with the
IFN inducer poly LC ; (3) blast NK cells isolated from poly EC-treated BALB/c nude mice ; (4)
blastT cells isolated fromC3H mice on day7 post-infection with LCMV; (5) blast cells isolated
from C3H mice on day 3 post-infection with LCMV; (6) blast cells from C3H mice that had
been treated with high-dose rIL-2; (7)Con A-induced Tcells ; (B) a second IL-2-dependent line ;
and (9) amouse fibroblastoid cell line. The left panel shows hybridization using 32P-labeled probe
complementary to the IL-2-R p55a chain gene. The right panel shows hybridization using 32p_
labeled probe for the actin gene .
is induced in vivo when T cells are dividing on day 7 post-infection with LCMV
(18), and p55 transcripts were also readily detectable with RNA isolated from these
cells (Fig. 3, lane 4) . Greater than 80% of the blast non-B lymphocytes on day 7
post-infection wereT cells (4) . The p55 chain transcripts were marginally detect-
able on day 3 post-infection with LCMV, the peak ofNK cell proliferation (Fig.
3, lane 5) . It was not possible to demonstrate transcripts for the IL-2-R p55 chain
with RNA prepared from either euthymic or athymic blast cell populations thathad
been elicited by poly I:C (Fig . 2, lanes 2 and 3) . As the blast populations elicited
in response to the IFN inducer are >75% CD3 - NK cells (4), these results conclu-
sively demonstrate that IFN-induced blast NK cells do not transcribe detectable
levels of the IL-2-R p55 gene .
To determine the proportion of the cells that were positive fora chain transcrip-
tion, in situ hybridization was carried out with the probe for the p55 gene (Table
III) . Controlnon-13 blast lymphocyteswere only 5% positive, and IFN-induced non-B
blastlymphocytes were only 7°lo positive forachain transcription by in situ hybrid-
ization . In contrast, the non-B blast lymphocytes prepared from euthymic mice after
treatment with high-dose rIL-2 were 41% positive (Table III) . Although treatment
of athymic mice with high-dose rIL-2 induced NK cell blastogenesis, only 12% of
the non-B blast lymphocytes were positive for transcription of the p55 gene (Table
III) . These results show that the p55 gene is not induced in high numbers of NK
cells from IL-2-treated athymic mice.
As 41% of the blast lymphocytes isolated from euthymic mice after IL-2 treat-182 RESPONSIVENESS OF NATURAL KILLER CELLS TO INTERLEUKIN 2
Cells
TABLE III
Proportion of Cells Positivefor IL-2-R p55 Gene Transcription
Evaluated by In Situ Hybridization
Percent Positive
t SD
Control mice, mice treated with high-dose rIL-2, and mice treated with high-
dose IFN-0 were used for these experiments. In situ hybridizations were car-
ried out as described in Materials and Methods. Percentages were determined
by counting grains over 200 cells per slide. The number of grains per cell con-
stituting a positive was determined in each experiment based on background
controls and negative controls. Results presented represent the means of two
to five slides done during one to four experiments.
Cells in these experiments were also examined for hybridization to a probe
complementary to the murine IL-2 gene. All of the populations had <10%
of the cells hybridizing to this probe.
ment expressed the p55 gene, it was necessary to determine whether the positive
cells were NK cells or other cells such as T cells. The NK1.l + cells were isolated
from control and IL-2-treated C57BL/6 mice by FAGS. Less than 5% of the total
NK1.1 * cells isolated from either control, untreated mice, or rIL-2-treated mice
were positive for p55 chain transcripts (Table III). These percentages were lower
than those observed in total non-B lymphocyte populations. Taken together, the data
demonstrate that murine NK cells are not induced to transcribe detectable levels
of the IL-2-R p55 a chain gene in response to IL-2 underthese in vivo conditions.
Kinetics of IL-2-R p55 a Chain Gene Expression During Infection with LCMV.
￿
Tran-
scripts for thep55a chain gene were marginally detectable with RNA isolated from
blast non-B lymphocytes on day 3 post-infection, but expressed at high levels on
day 7 post-infection with LCMV (Fig. 3). To examine the kinetics of a chain tran-
scription during infection more closely, total non-B lymphocytes were prepared for
in situ hybridizationon days 0, 3, 5, 7, and9post-infection ofC3H mice with LCMV
This approach requires much fewer numbers of cells than does Northern blot anal-
ysis and makes possible the determination ofpercentages of positive cellswithin mixed
populations. Transcripts for the IL-2-R p55 gene were expressed in significant per-
centages of cells, 12-18%, on days 5, 7, and 9 post-infection (Fig. 4). As NK cell
proliferation peaks on day 3 and subsides by day 7 post-infection (15), these results
demonstrate that the kinetics of the accumulation of IL-2-R p55 a chain gene tran-
scripts are distinct from the kinetics of NK cell proliferation during infection.
Expression ofIFN--y.
￿
Northern blot analysis with a probe fortheIFN-y gene was
carried out to demonstrate that the blast lymphocytes elicited in vivo had been in-
IL-2-activated nu/nu BALB/c mice 11 .8 f 5.7'
Total non-B lymphocytes isolated from:
Control C57BL/6 mice 6.5 f 2 .1"
IL-2-activated C57BL/6 mice 11 .8 t 4.3
NK1 .1 + cells isolated from:
Control C57BL/6 mice 4.8 t 1 .4
IL-2-activated C57BL/6 mice 3.5 t 3.5
Blast size non-B lymphocytes isolated from:
Control C3H mice 4.9 t 1.7'
IFN-activated C57BL/6 mice 7.3 t 3.1'
IL-2-activated C3H mice 40.6 t 8.8'0
0 2
￿
8 8 10
Days POSt"IMWIOn
BIRON ET AL .
￿
183
FIGURE 4 .
￿
Kinetics of IL-2-R p55 a chain transcription
duringLCMV infection of euthymic mice. Non-Blympho-
cytes were prepared fromC3Hmice on days 0, 3, 5, 7, and
9 post-infection with LCMV. The cells were fixed and ex-
amined by in situ hybridization with 35S-labeled probe
complementary for the IL-2-R p55achain gene. The con-
ditions for hybridization are as described in Materials and
Methods . Plotted are percentages of cells with high inten-
sity of hybridization (>5-10 grains per cell) for the IL-2-R
p55 chain probe . Results aremeans of6-18 slides from three
to nine separate experiments . Bars show SD of the means .
FIGURE 5 .
￿
Northern blot analysis for expression of the
IFN-y gene . CellularRNAwas prepared from control cells
and blast non-B lymphocytes elicited in vivo . The blot is
as described in Fig . 3 . Hybridization using 32p-labeled
probe complementary to the IFN-y gene is shown .
duced to express a gene associated with lymphocyte activation . All of the in vivo
elicited blast lymphocyte populations were activated to transcribe the gene forIFN- ,y
(Fig. 5). These included the blast cells that did not express the IL-2-R p55 a chain
gene, i.e ., those elicited by IL-2 in athymic mice and elicited by poly I :C in both
athymic and euthymic mice (Fig. 5, lanes 2, 3, and 5) .
Discussion
The data presented in this paper conclusively demonstrate that IL-2 can induce
the proliferationofNK cells in vivo. The cells are clearly dividing as they are under-
going blastogenesis, are driven into S and G2/M phases of the cell cycle, and in-
crease in number. The results also show that murine T cells are activated to tran-
scribe the IL-2-R p55 a chain gene in response to IL-2 in vivo. In contrast, blast
NK cells, elicited under a variety of in vivo conditions, including treatment with
IL-2 and/or IFNs, do not express detectable levels of the p55 gene . These results
thoroughly characterize the responsiveness of murine NK cells to IL-2 in vivo.
The NK cells examined in this study were responding to IL-2 signals in the ab-
sence of detectable p55 a chain transcripts . The receptor for IL-2 is made up of184 RESPONSIVENESS OF NATURAL KILLER CELLS TO INTERLEUKIN 2
several molecules, including a p70/75)3 chain, as well as the p55 ac chain (35-37).
Independently, the p70/75 and the p55 chains have low to intermediate affinity for
IL-2. Most restingcells do not express the p55 molecule ontheirsurfaces. Exposure
to IL-2 has been shown to induce transcription and production of the p55 chain
(33, 34). The p70/75 and p55 molecules combine to form a high affinity receptor
(35, 36). Although the p55 molecule can not function independently, the p70/75
a chain of the IL-2-R can bind to IL-2 and deliver proliferation signals in the ab-
sence ofthe p55 chain. It is possible, therefore, for NK cells to directly respond to
administered IL-2 in the absence of a p55 chain.
We appreciate the fact that p55 a chain expression can be regulated by complex
mechanisms at both theRNA and protein levels (38). Although negative results are
limited by the detectionmethods used, threesensitive techniques were used in these
studies to examine NK cell expression ofthe p55 chain. The expression ofthe p55
molecule could not be demonstrated by staining ofin vivo elicited cells with mAbs
directed against ap55protein determinant (datanot shown). Northern blotanalysis
showed that p55 transcripts were not detectable with RNA isolated from the total
population ofblast cells elicited underconditions that induce NKcell blastogenesis
in vivo. The in situ hybridizations were carried out todeterminewhether small subsets
ofcellswithin the mixedproliferatingpopulations and highly purifiedcells expressed
the gene, and these studies demonstrated that the vast majority of NK cells were
not induced to express the p55 gene. The results clearly show that, under the condi-
tions examined, p55 gene expression is dramatically more apparent when murine
T cells are activated than when murine NK cells are activated. These data help to
explain thestudies ofWagnerand Nelson (39), demonstratingthat, although repeti-
tive administration ofIL-2 activated NK cells in both euthymic and athymic mice,
solubleIL-2-R p55 chaincould only be demonstrated in theeuthymic mice. Whether
or not other stimuli or secondary stimuli would augment p55 expression with NK
cells remains to be determined. Workdone by other investigators has suggested that
the p55 chain may contribute to the maturation ofNK-like killer cells (40), and the
chemotactic responsiveness of LGLs isolated from the peritoneum (41).
The results presented here are in contrast to those that have been reported with
human NK cells. The p55 a chain is readily induced in vitro in human NK cells
after exposure to IL-2 (33, 34), and/or after signally through the Fc receptor on the
surface of NK cells (38). The difference between those experiments and the ones
reported here could be speciesdifferences orthe result ofdoing experiments invitro
vs. in vivo. The former is more likely, as expression ofthe p55 gene can not be de-
tected inhighly purified murine NK cells exposed to rIL-2 in vitro(Dr. VinayKumar,
personal communication).
As transcription of the p55 gene is more apparent when murine T cells are acti-
vated than when murine NK cells are activated, the activated T cells may have a
competitive advantage over NKcells in binding IL-2. Such an interpretation could
explaintheapparent lack ofNKcell proliferation atpeak times forIL-2 production
during viral infections ofeuthymic mice (18). At these times, the NK cells would
not successfully compete with T cells forendogenously produced IL-2. It isnot clear
whetheror not endogenously produced IL-2 is an important growth factor for NK
cells under any conditions. The recent demonstration of detectable p70/75 mole-
cules onnormal human peripheral NKcells, but notnormal peripheral Tcells (42),BIRON ET AL.
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suggests that at earlytimes during an immune response, NK cells may have an ad-
vantage over T cells in binding the factor. As the binding by the p70/75 receptor
is oflower affinity, however, conditions for high IL-2 production in the absence of
Tcell activation would have to exist. We are carrying out experiments using virus-
infected CD8 cell-depleted mice to ask if endogenously produced IL-2 can drive
NK cell proliferation. The virus-infected and CD8 cell-depleted mice have highly
active CD4+ T cells producing IL-2, but lack the major proliferating CD8+ T cell
subset. It appears that endogenously produced IL-2 can support the proliferation
of NK cells in these animals, as the kinetics of NK cell proliferation in CD8
cell-depleted mice extends into periods ofIL-2 production (Biron, C. A., K. Leite-
Morris, and M. T. Kasaian, unpublished results).
Although IL-2 is clearly inducing NK cell proliferation in these experiments, it
is not possible to definitively state that all of the observed effects are mediated by
direct stimulation ofNK cells. An 18-24-h period is required to observe DNA syn-
thesis by resting cells in response to proliferaton signals. The experiments reported
here were all carried out within a 24-h period to maximize direct consequences of
IL-2 exposure and minimize the production ofintermediary molecules. However,
as transcription of IFN-y was induced, and as we have previously shown that ad-
ministrationofIFN-y can induce NKcell proliferationin vivo (19), the contribution
made by IL-2-induced IFN-y is difficult to evaluate. IFN product could not be de-
tected in the serum of mice treated with IL-2 for 24 h (data not shown). Experi-
ments are in progress with neutralizing mAbs directed against IFN-'r to directly
examine the role of this factor during IL-2-driven NK cell proliferation in vivo.
In conclusion, the work presented in this paper clearly shows that NK cells can
proliferate in response to IL-2 in vivo. The results suggest that activated T cells in
mice haveacompetitive advantage forthe growth factor, as they areinducedto tran-
scribe theIL-2-R p55 achain gene, whereas the NKcells are not induced to express
detectable levels of this gene. The data help to explain the previously reported ki-
netics of NK cell and T cell proliferation during viral infections.
Summary
The growth factor, IL-2, was administered tomiceto evaluate 'the in vivo respon-
siveness ofNK cells to this factor. The immediate effects ofthis factor on NK cells
were determined by examining cytotoxic activity at 18-24 h after a single treatment
with rIL-2. Although moderate doses of rIL-2 (3 x 104 U) could be shown to acti-
vate existing cytotoxic cells on a per cell basis, higher doses (106 U) were required
to elicit blast size killer cells. The elicited killer cells were characterized as NK cells
by the following criteria: (a) they were readily induced in athymic mice; (b) they
mediated killing ofNK-sensitive YAC-1 target cellsbutnot NK-resistant P815 target
cells; and (c) they expressed the NK cell determinants asialo ganglio-n-tetraosylce-
ramide and NK1.1, but not the T cell determinants CD3, L3T4, or Lyt-2. High-
dose IL-2 treatment induced not only the appearance of blast size NK cells, but
alsotheexpansion ofthis population. Aftertreatments, the number oflarge granular
lymphocytes and the numberofNKIV cells were increased at least twofold. Anal-
ysis of DNA content within the NK1.1+ cell subset demonstrated that IL-2 prefer-
entially drove NKIV cells into S and G2/M phases of the cell cycle.
The in vivo elicited blast lymphocytes were examined by Northern blot analysis186 RESPONSIVENESS OF NATURAL KILLER CELLS TO INTERLEUKIN 2
and in situ hybridization for expression of the IL-2-R p55 a chain gene. As previous
work from this laboratory has demonstrated that NK cells proliferate in response
to IFNs and IFN inducers in vivo, blast lymphocytes were also prepared after IFN
treatments. The NK cells were not induced to express detectable levels ofthe a chain
gene under any of the conditions examined. Blast T lymphocytes, isolated at times
during viral infections when IL-2 production can be demonstrated in vitro, were
induced to transcribe the a chain gene. Treatments ofeuthymic mice with high-dose
IL-2 also induced transcription of the a chain gene in 41%v of the non-B blast lym-
phocytes, but only background percentages of the NK1.1 + cells expressed the a
chain gene. Transcription ofthe a chain gene was not induced in the NK cell-abun-
dant athymic mice after IL-2 treatment. All of the in vivo elicited blast lymphocytes
were induced to express IFN-ti. Taken together, these data definitively demonstrate
that IL-2 can induce NK cell proliferation and expansion in vivo. They also show
that exposure to IL-2 in vivo, either by administration or endogenous production
of the factor, induces transcription of the IL-2-R a chain gene in populations of
cells containing T cell subsets. The results suggest, however, that murine NK cells
are not induced to express high levels ofthe a chain gene in response to IL-2 in vivo.
We thank Kimberly Leite-Morris and Kirsten Pedersen for technical assistance and Cetus
Corp. for kindly providing the rIL-2 used in these studies.
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